These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 35869353)

  • 1. Post-COVID-19 condition is not only a question of persistent symptoms: structured screening including health-related quality of life reveals two separate clusters of post-COVID.
    Giszas B; Trommer S; Schüßler N; Rodewald A; Besteher B; Bleidorn J; Dickmann P; Finke K; Katzer K; Lehmann-Pohl K; Lemhöfer C; Pletz MW; Puta C; Quickert S; Walter M; Stallmach A; Reuken PA
    Infection; 2023 Apr; 51(2):365-377. PubMed ID: 35869353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the remote early detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial.
    Brakenhoff TB; Franks B; Goodale BM; van de Wijgert J; Montes S; Veen D; Fredslund EK; Rispens T; Risch L; Dowling AV; Folarin AA; Bruijning P; Dobson R; Heikamp T; Klaver P; Cronin M; Grobbee DE;
    Trials; 2021 Jun; 22(1):412. PubMed ID: 34158099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the Remote Early Detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial.
    Brakenhoff TB; Franks B; Goodale BM; van de Wijgert J; Montes S; Veen D; Fredslund EK; Rispens T; Risch L; Dowling AV; Folarin AA; Bruijning P; Dobson R; Heikamp T; Klaver P; Cronin M; Grobbee DE;
    Trials; 2021 Oct; 22(1):694. PubMed ID: 34635140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody tests for identification of current and past infection with SARS-CoV-2.
    Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Spijker R; Taylor-Phillips S; Adriano A; Beese S; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Dittrich S; Emperador D; Hooft L; Leeflang MM; Van den Bruel A;
    Cochrane Database Syst Rev; 2020 Jun; 6(6):CD013652. PubMed ID: 32584464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Universal screening for SARS-CoV-2 infection: a rapid review.
    Viswanathan M; Kahwati L; Jahn B; Giger K; Dobrescu AI; Hill C; Klerings I; Meixner J; Persad E; Teufer B; Gartlehner G
    Cochrane Database Syst Rev; 2020 Sep; 9(9):CD013718. PubMed ID: 33502003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A longitudinal SARS-CoV-2 biorepository for COVID-19 survivors with and without post-acute sequelae.
    LaVergne SM; Stromberg S; Baxter BA; Webb TL; Dutt TS; Berry K; Tipton M; Haberman J; Massey BR; McFann K; Alnachoukati O; Zier L; Heacock T; Ebel GD; Henao-Tamayo M; Dunn J; Ryan EP
    BMC Infect Dis; 2021 Jul; 21(1):677. PubMed ID: 34256735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistent COVID-19 symptoms in a community study of 606,434 people in England.
    Whitaker M; Elliott J; Chadeau-Hyam M; Riley S; Darzi A; Cooke G; Ward H; Elliott P
    Nat Commun; 2022 Apr; 13(1):1957. PubMed ID: 35413949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long COVID symptoms in SARS-CoV-2-positive adolescents and matched controls (LongCOVIDKidsDK): a national, cross-sectional study.
    Kikkenborg Berg S; Dam Nielsen S; Nygaard U; Bundgaard H; Palm P; Rotvig C; Vinggaard Christensen A
    Lancet Child Adolesc Health; 2022 Apr; 6(4):240-248. PubMed ID: 35143771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two-month follow-up of persons with SARS-CoV-2 infection-Zambia, September 2020: a cohort study.
    Zulu JE; Banda D; Hines JZ; Luchembe M; Sivile S; Siwingwa M; Kampamba D; Zyambo KD; Chirwa R; Chirwa L; Malambo W; Barradas D; Sinyange N; Agolory S; Mulenga LB; Fwoloshi S
    Pan Afr Med J; 2022; 41():26. PubMed ID: 35291364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of the Frequency and Variety of Persistent Symptoms Among Patients With COVID-19: A Systematic Review.
    Nasserie T; Hittle M; Goodman SN
    JAMA Netw Open; 2021 May; 4(5):e2111417. PubMed ID: 34037731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain Fog and Quality of Life at Work in Non-Hospitalized Patients after COVID-19.
    Chatys-Bogacka Z; Mazurkiewicz I; Slowik J; Bociaga-Jasik M; Dzieza-Grudnik A; Slowik A; Wnuk M; Drabik L
    Int J Environ Res Public Health; 2022 Oct; 19(19):. PubMed ID: 36232113
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy of hydroxychloroquine for post-exposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among adults exposed to coronavirus disease (COVID-19): a structured summary of a study protocol for a randomised controlled trial.
    Barnabas RV; Brown E; Bershteyn A; Miller RS; Wener M; Celum C; Wald A; Chu H; Wesche D; Baeten JM;
    Trials; 2020 Jun; 21(1):475. PubMed ID: 32493478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long COVID symptoms in SARS-CoV-2-positive children aged 0-14 years and matched controls in Denmark (LongCOVIDKidsDK): a national, cross-sectional study.
    Kikkenborg Berg S; Palm P; Nygaard U; Bundgaard H; Petersen MNS; Rosenkilde S; Thorsted AB; Ersbøll AK; Thygesen LC; Nielsen SD; Vinggaard Christensen A
    Lancet Child Adolesc Health; 2022 Sep; 6(9):614-623. PubMed ID: 35752194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-lasting Symptoms After an Acute COVID-19 Infection and Factors Associated With Their Resolution.
    Robineau O; Zins M; Touvier M; Wiernik E; Lemogne C; de Lamballerie X; Blanché H; Deleuze JF; Saba Villarroel PM; Dorival C; Nicol J; Gomes-Rima R; Correia E; Coeuret-Pellicer M; Druesne-Pecollo N; Esseddik Y; Ribet C; Goldberg M; Severi G; Carrat F;
    JAMA Netw Open; 2022 Nov; 5(11):e2240985. PubMed ID: 36350653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of Life (QoL) Is Reduced in Those with Severe COVID-19 Disease, Post-Acute Sequelae of COVID-19, and Hospitalization in United States Adults from Northern Colorado.
    McFann K; Baxter BA; LaVergne SM; Stromberg S; Berry K; Tipton M; Haberman J; Ladd J; Webb TL; Dunn JA; Ryan EP
    Int J Environ Res Public Health; 2021 Oct; 18(21):. PubMed ID: 34769566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-COVID-19 symptoms 6 months after acute infection among hospitalized and non-hospitalized patients.
    Peghin M; Palese A; Venturini M; De Martino M; Gerussi V; Graziano E; Bontempo G; Marrella F; Tommasini A; Fabris M; Curcio F; Isola M; Tascini C
    Clin Microbiol Infect; 2021 Oct; 27(10):1507-1513. PubMed ID: 34111579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.